NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of
the securities of TG Therapeutics, Inc. (NASDAQ:TGTX) from June 4, 2018
through September 25, 2018, inclusive (the “Class Period”) of the
important December 3, 2018 lead plaintiff deadline in the class action.
The lawsuit seeks to recover damages for TG Therapeutics investors under
the federal securities laws.
To join the TG Therapeutics class action, go to https://www.rosenlegal.com/cases-1426.html
or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at
866-767-3653 or email email@example.com
for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS
MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN
ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD
According to the lawsuit, defendants throughout the Class Period made
false and/or misleading statements and/or failed to disclose that: (1)
TG Therapeutics was involved in cleaning data collected from its
UNITY-CLL study and was therefore able to gain an understanding of the
efficacy of the combination therapy; (2) due to the data cleaning, TG
Therapeutics knew the UNITY-CLL study had failed to meet its stated goal
and therefore knew it would be unable to seek accelerated approval; (3)
as a result of the foregoing, it was highly unlikely that the
combination therapy would meet its primary endpoint of increased
progression free survival; and (4) consequently, defendants’ statements
during the Class Period were materially false and misleading and/or
lacked a reasonable basis at all relevant times. When the true details
entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than December 3, 2018.
A lead plaintiff is a representative party acting on behalf of other
class members in directing the litigation. If you wish to join the
litigation, go to https://www.rosenlegal.com/cases-1426.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law
Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm
or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
275 Madison Avenue, 34th Floor
York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653